Three trials included patients with DLBCL who receive rituximab maintenance therapy
immediately after induce chemotherapy.
with methadone or buprenorphine might have the added benefit of reducing the risk of hepatitis C virus infection, with an observational cohort study showing a 69% decrease in the rate of infection among injecting drug users.
Washington, Dec 4 (ANI): Researchers from Saint Louis University have revealed that 'maintenance therapy
' involving low-dose peginterferon has been found ineffective in patients with advanced hepatitis C.
StraRera (atomoxetine HCI, Eli Lilly & Co.) The Food and Drug Administration approved Strattera for attention-deficit/hyperactivity disorder maintenance therapy
in children and adolescents aged 6 years and older.
And lots of our patients can't take isotretinoin for one reason or another; for them, maintenance therapy
is going to be necessary.
Furthermore, the relapse rate was significantly higher in the 50 case patients who were not on IBD maintenance therapy
, compared with those who were on maintenance therapy
Sandostatin LAR is indicated for long-term maintenance therapy
in acromegalic patients for whom medical therapy is appropriate and who have been shown to respond to and can tolerate Sandostatin(r) (octreotide acetate) injection.
On the other hand, if such a patient has only supine or upright reflux disease, a single daily dose might suffice as maintenance therapy
after the acute phase of the illness has resolved.
Roche said Valcyte will become the first orally administered CMV therapy approved by the FDA for both induction and maintenance therapy
in AIDs patients.
Study design and validity This was a randomized double-blind placebo-controlled study of omeprazole 10 mg per day for the maintenance therapy
of erosive esophagitis.
Then the researchers randomly assigned the study participants to nine months of maintenance therapy
with either a low dose of 13-cis-retinoic acid or beta carotene, a natural vitamin A precursor found in many orange fruits and vegetables.
In fact, recombinant DNA technology may significantly reduce the costs of long-term maintenance therapy
either through the development of recombinant substitutes or through specific gene therapy.